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Purpose: The goal of our study was to investigate changes in intraocular pressure (IOP),
best-corrected visual acuity (BCVA), and retinal nerve fibre layer thickness (RNFLT) after
CO2 laser-assisted deep sclerectomy (CLASS).
Methods: We carried out uncomplicated CLASS surgeries and a 12-month follow-up on 22
open-angle glaucomatous (OAG) eyes of 22 patients. IOP, BCVA, and RNFLT with spectral-
domain optical coherence tomography (SD OCT) were recorded before and 1, 3, 6, 12
months after surgery.
Results: Mean age of patients was 68.1 years. IOP decreased from preoperative 28.45±5.99
SD mmHg (mean±standard deviation) to 15.09±2.40 mmHg (p=0.00039) at 12 months after
surgery. BCVA-change from preoperative 0.34±0.38 SD (LogMAR) to 0.37±0.41 SD
(LogMAR) was not significant (p=0.2456). RNFLT-change from preoperative 60.50
±18.15µm to 59.63±17.52 µm at 12 months postoperatively was not significant (p=0.056).
Qualified success rate of CLASS surgery was 72.7%, whereas complete success rate was
64% at 1 year postoperatively.
Conclusion: Successful CLASS surgery efficiently reduced IOP. At postoperative 12
months, RNFLT and BCVA were not reduced significantly. There was no significant glau-
comatous progression after surgery encountered in respect of investigated parameters.
Keywords: open-angle glaucoma, CLASS, retinal nerve fiber layer thickness, intraocular
pressure, best-corrected visual acuity
Introduction
Open-angle glaucoma is a chronic, progressive optic neuropathy, which primarily
affects retinal ganglion cells (RGC) and in the lack of adequate treatment eventually
leads to gradual visual field- and visual acuity-loss. Insufficient IOP control and
function loss in spite of maximal conservative therapy is an indication for surgical
intervention.1 An adequate treatment option may be non-penetrating deep sclerect-
omy (NPDS), which was proven to be adequately efficient and has a higher safety
profile (lower complication rate) than traditional trabeculectomy.2,3 Undesired
perforation rate during the preparation of trabeculo-Descemet window might be
as high as 30–50%.4 In order to reduce intraoperative complication rate in the
course of non-penetrating deep sclerectomy, and to increase standardization and
reproducibility of the surgery, CO2 laser was introduced in the surgical procedure.5
Publications about the human application of CO2 laser-assisted sclerectomy
surgery (CLASS) see back only a few years now.6,7 Several authors report on the
efficacy of the surgery. According to their results, CLASS surgery reduces IOP very
efficiently, at the same time, it also has a high postoperative total success and
Correspondence: Zoltán Sohajda
Email zoltansohajda@hotmail.com
Clinical Ophthalmology Dovepress
open access to scientific and medical research
Open Access Full Text Article
submit your manuscript | www.dovepress.com Clinical Ophthalmology 2020:14 1749–1757 1749
http://doi.org/10.2147/OPTH.S247595
DovePress © 2020 Sohajda et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the
work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
 
Cl
in
ica
l O
ph
th
al
m
ol
og
y 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
16
0.
11
4.
99
.3
7 
on
 1
0-
Ju
l-2
02
0
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
qualified success rate.6–9 Geffen et al report about signifi-
cant and permanent IOP reduction even after a 3-year
follow-up time.10 In the latest study on the issue by
Jankowska-Szmul, the efficacy of CLASS surgery and
trabeculectomy was compared. She found that both sur-
geries reduce IOP efficiently, nevertheless, trabeculectomy
results in a more pronounced IOP reduction. However,
there is no significant difference in the qualified success
rate of the two surgeries. At the same time, CLASS is
accompanied by significantly fewer complications than
trabeculectomy.11 Yu et al combined CLASS and phacoe-
mulsification to reach efficient IOP-reduction.12 There is
much less publications on the change of morphological
parameters after non-penetrating glaucoma surgery, how-
ever. We only have information about the average RNFL-
and thus indirectly about RGC – status in the postoperative
first 6 months.13–15 The goal of this prospective study was
to investigate changes in IOP, best-corrected visual acuity
(BCVA) and retinal nerve fibre layer thickness (RNFLT) in
the course of a 12-month follow-up period after CLASS
surgery, was carried out on open-angle glaucomatous eyes.
Subjects and Methods
All procedures adhered to the Declaration of Helsinki. This
studywas approved by the local Ethics Committee of Kenézy
University Hospital. A written informed consent from all
patients were obtained before the operation. Eligible patients
were adults (>40 years) with medically uncontrolled open-
angle glaucoma (primary open-angle glaucoma, pseudoexfo-
liative glaucoma). Medically uncontrolled was defined when
no adequate glaucoma-control could be reached in spite of
maximal local hypotensive therapy. Under such circum-
stances a glaucomatous optic neuropathy, progression of
glaucomatous visual field defect, or worsening of RNFLT
an open-angle (Schaffer III–IV grade) were indications for
surgery. Exclusion criteria were: any intraocular surgery
within 6 months, previous glaucoma surgery or laser proce-
dure, any kind of vascular retinopathy, an optic neuropathy
not attributable to glaucomatous damage and a myopic or
hyperopic refractive error greater than 6D. All patients
underwent a comprehensive ophthalmological examination
at baseline and at 1, 3, 6 and 12 months postoperatively.
These included a thorough history record, assessment of
BCVA (LogMAR), anterior segment and fundus examina-
tion, Goldmann applanation tonometry, gonioscopy, pachy-
metry (IOL Master-700 Carl Zeiss Meditec, AG, Jena,
Germany). Patients underwent visual field test (Humphrey
Field Analyzer II 750, Carl Zeiss Meditec, Inc., Dublin,
USA; 24–2 SITAFAST protocol). A reliable visual field
test was defined as one with less than 30% fixation loss and
false positive or false negative responses. RNFLT measure-
ments were carried out with spectral-domain optical coher-
ence tomography (Spectralis, Heidelberg Engineering
GmbH, Heidelberg, Germany; Spectralis Glaucoma
Module Premium Edition, version: GMPE V6.8a). Visual
field and/or RNFL-changes were taken into account when
indicating surgery.12,14 Surgery was considered to be suc-
cessful if the following criteria were met: postoperative IOP
was between 5 and 18mmHg and at least 20% IOP-reduction
was achieved as compared to baseline with (qualified success
rate) or without (complete success rate) additional local
hypotensive therapy.6 If IOP was not in the above range in
spite of administering maximal hypotensive therapy, we car-
ried out Nd:YAG goniopuncture or needling. Patients with an
intraoperative complication (macroperforation), high post-
operative IOP (reoperation needed) or intraocular surgery
within the 1-year interval of follow-up, were excluded from
the study. Data of 22 patients’ 22 eyes (out of 25 patients at
baseline) over a 12-month follow-up period were analysed.
We did not include a control group. To be ethical we per-
formed the surgery in all cases when the need for surgical
intervention was recognized (non-compensated cases on con-
servative therapy).
Surgical Procedure
All surgeries were performed by the same surgeon (Z.S.)
under retrobulbar anaesthesia (1:1 mixture of bupivacaine
0.5% and lidocaine 2%). CLASS surgeries were carried
out according to the standard technique, without using
antimetabolite.9,10 A peritomy with removal of the Tenon
capsule and a careful cauterization was carried out in the
superior quadrant. A 4x4 mm half-thickness scleral flap
was dissected manually at the 12-o’clock position and
a scleral pond was created with OT-135 CO2 laser device
(IOPtiMate; IOPtima Ltd, Ramat Gan, Israel) using 20W
laser energy. CO2 laser beam was then focused at the
surgical limbal area, and thus, with the dissection of
Schlemm’s canal and the trabeculum a 3mm wide trabe-
culo-Descemet window was created. A well functioning
window was hallmarked by fluid percolation from the
anterior chamber. A high viscosity viscosurgical device
(Amvisc Plus, Bausch+Lomb, USA) was injected into
the scleral bed, and then the sclera and conjunctiva were
closed with 8/0 Vicryl sutures. Patients were administered
Tobramycin+Dexamethason drops 4 times daily for 1
month.
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Statistical Analysis
Snellen BCVA values were converted to the logarithm of
the minimum angle of resolution (logMAR). Descriptive
statistical results were presented as mean ± standard devia-
tion (SD). Changes from baseline of continuous variables
to different endpoints were analysed with Wilcoxon test.
Cumulative probability of success was illustrated using
Kaplan–Meier survival curves. Multiple logistic regression
analysis was performed to investigate the relationship
between the different investigated variables. Spearman
correlation was used to describe correlations between
age, baseline IOP and change, baseline RNFLT and
change, baseline BCVA and change. A p value of <0.05
was considered significant. Analysis was performed in
R software package, version 3.5.2 (R Core Team 2018).
Results
The study period was from January 2016 to June 2018. Three
patients of all 25 were excluded from our study: trabeculect-
omy was performed in 2 cases because of intraoperative
macroperforation, and another CLASS surgery was performed
in 1 case in the first postoperative month. All of our patients
belong to the Caucasian race. Twenty-two open-angle glauco-
matous eyes (15 females, 7 males) were altogether enrolled in
this study, and followed for 12 months. Mean age of patients
was: 68.1 (46–87) years. In 4 cases of all 22 surgeries, an
intraoperative microperforation occurred. This, however, did
not disturb usual finishing of the surgery. We encountered
hyphaema as a complication in the early postoperative period
(1 month), which resolved spontaneously. Choroidal detach-
ment occurred postoperatively in one case (1 month), that
resolved without any additional surgical correction. We
needed to carry out needling in 4 cases and Nd:YAG gonio-
puncture in 4 cases in the first 3 postoperative months.
We analysed data at postoperative 1, 3, 6 and 12
months. We measured IOP, recorded BCVA, and evaluated
RNFLT on average and in each sector one by one (superior
nasal: SN, nasal: N, inferior nasal: IN, inferior temporal:
IT, temporal: T, superior temporal: ST). Patient’s clinical
characteristics are summarized in Table 1.
Mean preoperative IOP was 28.45 ± 5.99 SD mmHg,
which decreased to 16.0 ± 1.77 SD mmHg at 1st
(p=0.00039), to 16.72 ± 1.90 SD Hgmm at 3rd (p=
0.00058), to 15.54 ± 2.17 SD Hgmm at 6th (p=0.00039)
and to 15.09 ± 2.40 SD Hgmm at 12th (p= 0.00039) post-
operative month. Changes compared to baseline values were
all significant. Mean preoperative 0.34 ±0.38 SD BCVA
changed to 0.36 ± 0.39 SD (p=0.026), 0.37±0.40 SD
(p=0.055), 0.37 ± 0.41 SD (p=0.20) and 0.37±0.41 SD
(p=0.24), respectively. Improvements at 1 month were sig-
nificant, whereas changes at 3, 6 and 12 month were not
significant compared to baseline values.
Preoperatively measured RNFLTwas: 60.50 ± 18.15 SD
µm and then 62.27±18.20 SD µm (p=0.011), 59.72± 17.42
SD µm (p=0.26), 59.54±17.19 SD µm (p=0.074) and 59.63
±17.52 SD µm (p=0.0564), respectively, at each follow-up
time. At 1 month, RNFLT compared to baseline was statis-
tically significantly thicker, however, later on differences
were not significant (Table 2). Changes of BCVA, RNFLT
over time are shown in Figures 1 and 2. We also analysed
RNFLT in different sectors postoperatively. At 1 month,
RNFLT was statistically significantly thicker in many sec-
tors (SN,N,IN, IT, T) as compared to baseline: SN from
83.55±35.26 SD µm to 85.32±33.80 SD µm (p= 0.036),
N from 54.95± 19.91SD µm to 57.77±18.39 SD µm (p=
0.017), IN from 73.50± 24.8 SD µm to 74.91± 23.12 SD µm
(p= 0.032), IT from 75.14±37.17 SD µm to 77.86±34.52SD
µm (p= 0.025), T from 48.64±12.07 SD µm to 54.09±13.36
SD µm (p= 0.0007). RNFLT – change in ST sector was not
significant at 1 month: from 80.73± 35.62 µm to 82.91
±32.89, SD µm (p= 0.087). Apart from these, there were
no significant changes in RNFLT in any sectors within the
12 months. Data are presented in Figure 3. Figure 4 shows
a 62 years old male patient’s RNFLT in different sectors pre
and 12 months postoperatively (Figure 4A and B). We
intended to identify correlations (Pearson correlation)
between different investigated parameters: age, baseline
IOP and change, baseline RNFLT and change, baseline
BCVA and change. We found correlation merely between
BCVA-change and IOP-change (r2=0.234, p=0.022), and
between the baseline BCVA and baseline IOP (r2=0.281,
p=0.0112). We analysed the efficacy of CLASS surgery in
Table 1 Patient’s Clinical Characteristics Before the Surgery
Mean ± SD Range
Age (year) 68.1 ± 15.6 46–87
Medication 2.80 ± 0.75 1–4
CCT (µm) 542.25 ± 32.53 485–590
IOP (mmHg) 28.45 ± 5.99 18–42
MD (dB) −10.8 ± 8.3 −24.7 to 0.4
BCVA (logMar) 0.34 ± 0.38 0−1.0
RNFLT (µm) 60.50 ± 18.15 40–96
Abbreviations: CCT, central corneal thickness; IOP, intraocular pressure; MD,
mean deviation; BCVA, best-corrected visual acuity; RNFLT, retinal nerve fiber layer
thickness.
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respect of qualified success rate and complete success rate.
According to our results, qualified success rate was 90.9%
at 1 month, 86.3% at 3 months, 77% at 6 months and 72.7%
at 12 months postoperatively. Complete success rate was
86.3%, 77%, 72.7%, 64%, respectively. Figure 5 shows
Kaplan–Meier plots of cumulative probability of complete
success and qualified success.
Discussion
The efficacy of CLASS surgery in lowering IOP is con-
firmed by numerous studies.6,7,9–12 NPDS is the surgical
basis for CLASS surgery, and it was proved by Gesser to
efficiently stabilize visual field over an 8-year period.3
Greifner compared the efficacy of NPDS and CLASS in
terms of IOP-reduction, and reported total success rate and
qualified success rate of CLASS be better than that of
NPDS.16 IOP reduction is adequate 3 years postopera-
tively after CLASS.10 Our results of 72.7% qualified suc-
cess rate and 64% complete success rate at the 12 months
end point of follow-up are in accordance with the latest
reports on this issue, which report on 74–91% qualified
success rate and 35–73% complete success rate.10,12,16,17
Table 2 The Everage Data of Investigated Parameters Postoperatively
IOP ±SD p value BCVA±SD p value RNFLT±SD p value
Preop. 28.45 ±5.99 – 0.34±0.38 – 60.50±18.15 –
1 mo. 16.0±1.77 0.00039* 0.36±0.39 0.026* 62.27±18.20 0.011*
3 mo. 16.72±1.90 0.00058* 0.37±0.40 0.055 59.72±17.42 0.261
6 mo. 15.54±2.17 0.00039* 0.37±0.41 0.206 59.54±17.19 0.074
12 mo. 15.09±2.44 0.00039* 0.37±0.41 0.245 59.63±17.52 0.056
Notes: p: level of significance. P< 0.05 is marked *.
Abbreviations: IOP (Hgmm), intraocular pressure, BCVA (LogMAR), best-corrected visual acuity; RNFLT (µm), peripapillary nerve fibre layer thickness; SD, standard
deviation.
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Figure 1 Cumulative IOP ± SD measurements from the preoperative stage up to 12 months postoperatively.
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Figure 2 Cumulative RNFLT± SD measurements from the preoperative stage up to 12 months postoperatively.
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There are studies designed to examine functional para-
meters related to CLASS surgery; however, there is no
research article published on retinal morphological changes
after CLASS up to date. Optical coherence tomography
(OCT) provides a good possibility to demonstrate these
changes. It is a non-invasive, real-time and objective method
to scan retinal parameters quantitatively.14 IOP-changes cor-
relate well with RNFLT-changes. The most affected layer of
RNFL in respect of glaucomatous damage is located in the
level of lamina cribrosa. Structure of this layer, however, is
not uniform: it is thicker nasally than in other sectors.18 There
are studies conducted to evaluate the correlation between
different methods of glaucoma surgery and RNFLT. These
studies, however, are diverse, and investigate RNFLT-change
in terms of disparate surgical techniques. Part of these articles
report on an RNFLT-increase in the first 3–4 months post-
operatively after trabeculectomy. In these studies, it is sug-
gested that the thickness of prelaminar tissue is influenced by
IOP.13,15,19–21 According to research articles about NPDS,
postoperative IOP-reduction is not associated with signifi-
cant RNFLT-change at 6 months postoperatively.13,14 Studies
reporting on the condition of lamina cribrosa and peripapil-
lary RNFLT after trabeculectomy or NPDS draw the same
conclusion: changes in the morphology of the optic nerve
head attributable to postoperative IOP-changes (anterior dis-
placement of the lamina cribrosa, reduced cup volume and
increased rim area) are not necessarily accompanied by an
increase in the RNFLT.4,17,21–24 Reduction of cup volume
can be detected if significant IOP lowering (according to
some authors at least 30% or according to others even less)
is realized.13,22,25 Changes in RNFLT in correlation with IOP
changes were likewise measured. According to some
authors, there is an 0.5μm increase in RNFLT in case of
a 1mmHg IOP-reduction, according to others, a 1.3 mmHg
IOP-lowering is needed to achieve this goal.14,19,26 There is
not a tight correlation between the morphological changes of
the optic nerve head and RNFLT. Explanation for this obser-
vation might be that IOP-reduction does not result in an
increase of the number of axons, rather, it causes relaxation
of the axons and reduces tissue strain, and this would lead to
a morphological change of the optic nerve head. However,
this restoration is biomechanical or physiological, rather than
anatomical.14 Krzyżanowska-Berkowska et al studied the
differences between trabeculectomy and NPDS. They
found that the thickening of the prelaminary tissue area
(axons, capillaries, extracellular materials) after trabeculect-
omy was more explicit, than in the NPDS group.13 Hypotony
may result in an increase in the overall retinal thickness, and
this may account for the RNFLT-increase encountered after
trabeculectomy and more infrequently after NPDS. This fact
may lead to false interpretation of RNFLT-increase after
trabeculectomy.15,19,20 Authors evaluating RNFLT-changes
after NPDS surgery analyse patients’ records with dissimilar
pre- and postoperative RNFLT: Rebolleda measured 66.6 µm
mean RNFLT in her patients group, whereas Krzyżanowska-
Berkowska’s patients had 61.6 µm average RNFLT at base-
line. Among our subjects the mean RNFLT was 60.50µm at
baseline and 59.63µm at 12-month end point of the follow-
up. We compared our patients’ results of RNFLT-changes to
those of Rebolleda, who carried out NPDS surgery. It is
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Figure 3 Line graphs showing comparison of the six sectors of RNFL thickness at each control visit with respect to the baseline values.
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Figure 4 (A) Preoperative OCT image of a 62-year-old male patient displaying significantly reduced RNFLT in all except for the inferonasal sector. (B) RNFLT image of the
same patient 1 year postoperatively: significantly reduced RNFLT in all but the nasal and inferonasal sectors, mean RNFLT is unaltered.
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known that it is problematic to compare progression rates
expressed in terms of RNFLT-changes measured with differ-
ent OCT systems.13,14,28 Lower mean baseline RNFLT score
of our candidates indicates that patients in Hungary are
assigned for glaucoma surgery at a more advanced stage of
glaucomatous damage.27 Rebolleda found RNFLT-change to
be higher in patients with a preoperative RNFLTsmaller than
62 µm than in patients with a preoperative RNFLT higher
than 62 µm.14
When evaluating RNFLT-changes measured with spec-
tral-domain OCT, we must take into account the fact that
the average RNFLT-reduction per year might be as high as
0.33 µm in healthy eyes whereas 0.69 µm in glaucomatous
eyes being on maximal medical therapy.28 Mean RNFLT-
change in our subjects was -0.87µm at 12 months. This is
comparable to Holló’s previous data. Our data suggest that
CLASS as a non-penetrating procedure effectively reduces
RNFLT decrease on an overall 12-month follow-up.
Several other authors investigated RNFLT-change after
NPDS procedure and they found no significant changes
as compared to baseline at 6 months postoperatively.13,14
Krzyżanowska-Berkowska et al investigated RNFLT-
changes per sectors following NPDS surgery. At postopera-
tive 6 months, they observed a significant RNFLT-reduction
in TS and TI sectors but found no significant changes in the
rest of the 4 sectors or on average either.13 We encountered
a significant increase in mean RNFLT in almost all sectors
(except ST) and on average as well at 1 month after surgery.
Similar results were reported by many authors after trabecu-
lectomy and NPDS surgery in the early postoperative period.
The mechanism that could explain the thickening of RNFLT
after corresponding IOP reduction is unclear. It is possible,
however, that some axons are still able to function during
periods of elevated IOPs and can recover some physiologic
function after IOP is lowered.14 Nevertheless, at 6 and 12
months postoperatively there was no significant thinning in
the mean RNFLT either per sectors or on average as com-
pared to baseline.13,14,19,21 RNFLT-increase in the early post-
operative period might be attributed to the major IOP-
reduction encountered during this period, although we
could find no correlation between these two parameters.
We could only find correlation between BCVA-changes
and IOP-reduction: a greater IOP-reduction was accompa-
nied by a greater improvement in BCVA. Another correla-
tion was found between baseline IOP and baseline BCVA.
The higher the baseline IOP was, the lower the baseline
BCVA. According to Jankowska-Szmul and Cutulo, BCVA
does not change significantly after CLASS surgery.11,29 In
our study, we could confirm these findings. This might be
attributed to two different factors. The first is that there was
only a mild progression of cataract. The second is that there
was no significant change in RNFLT after NPDS surgery,
albeit the latter is one of the most important criterion of
maintaining a good visual function.1,13,14 An interesting
point in our study is that a significant temporary BCVA-
improvement at 1 month postoperatively was encountered.
There might be multiple reasons in the background of this
explanations for this finding. One is the thickening of
RNFLT, which can be attributed to the decompression of
axons after adequate IOP reduction.14 Next is the high
percentage of complete success rate observed in the early
postoperative period. The lower amount of eye drops used in
this period might account for an increased tear film stability
and thus the visual acuity improvement.30
To conclude, IOP control by successful CLASS may
result in stability of RNFL thickness after CLASS surgery
in the investigated period, while a significant IOP-
reduction was achieved at 12 months postoperatively.
Limitation of our study is the relatively small number of
patients enrolled. However, taking into account that to our
knowledge, there is no other study apart from ours up to
date dealing with this issue, this present research might be
a good baseline for further investigations.
Informed Consent
Informed consent was obtained from all participants
included in the study.
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Figure 5 Kaplan–Meier plots of the cumulative probability of complete success
(dashed line) and qualified success (continuous line) for CO2 laser-assisted scler-
ectomy surgery (CLASS).
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